XERIS PHARMACEUTICALS INC XERS 5 07.15.25
NOTE 5.000% 7/1 · US DOMESTIC · CUSIP 98422LAA5
6
institutional holders
+0 vs Q1 2021
250.0k
shares reported held*
$73.7mreported value*
0 new
1 added
2 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $294.84.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2020 | 22 |
| Q3 2020 | 16 |
| Q4 2020 | 8 |
| Q1 2021 | 6 |
| Q2 2021 | 6 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2020 | 7 | 14 |
| Q4 2020 | 3 | 8 |
| Q1 2021 | 3 | 1 |
| Q2 2021 | 1 | 2 |
Biggest buyers
| Sessa Capital IM, L.P. | Added | +775.0k |
Biggest sellers
| LAZARD ASSET MANAGEMENT LLC | Reduced | -625.0k |
| 683 Capital Management, LLC | Reduced | -150.0k |
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.51% of their portfolio | 18.0m $28.5m | Unchanged |
| LAZARD ASSET MANAGEMENT LLC 0.02% of their portfolio | 10.0m $15.7m | Reduced -625.0k |
| Sessa Capital IM, L.P. 0.86% of their portfolio | 10.0m $15.8m | Added +775.0k |
| 683 Capital Management, LLC 0.66% of their portfolio | 8.4m $13.3m | Reduced -150.0k |
| Saltoro Capital, LP 0.41% of their portfolio | 250.0k $392.0k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |